JOANNE JOHNSON: Open Payments
NPI 1063119113 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 36 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $173 |
| Novo Nordisk Inc | 3 | $159 |
| SANOFI-AVENTIS U.S. LLC | 2 | $141 |
| ABBVIE INC. | 8 | $136 |
| PFIZER INC. | 4 | $65 |
| ViiV Healthcare Company | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Ozempic, TZIELD, AIRSUPRA, QULIPTA, BREZTRI, PREVNAR 20, UBRELVY, DOVATO.
Industry payments across AR — which companies pay providers there.
